In 2011, a man who had spent five years running an insurance company in India walked away to sell the one thing insurers had spent decades avoiding: the everyday doctor visit. Varun Gera had grown UnitedHealthcare India roughly five-fold to about 1.5 million members between 2006 and 2011, then left to build HealthAssure around outpatient care (OPD) — the consultations, tests and pharmacy runs that rarely trigger a hospital claim and so almost never got insured.
Fifteen years on, the bet has hardened into infrastructure. HealthAssure has wired roughly 3,200 primary-care centres across more than 1,000 Indian cities into a single network that insurers such as LIC and SBI Life, and employers such as GE, Deloitte and Deutsche Bank, now plug into rather than build. The company says it has serviced more than 3 million customers since 2011 and raised its largest round, ₹50 crore, in August 2022. Yet its reported revenue sits in the tens of crore, its profitability is not cleanly disclosed, and the OPD-insurance category it helped create is still, by its own framing, mostly a promise about a market it pegs near $40 billion.
Quick facts
| Company | HealthAssure Private Limited (CIN U85100MH2011PTC223007), Mumbai |
| Founded | Incorporated 14 October 2011 (Registrar of Companies, via Tofler) |
| Founder(s) | Varun Gera (Founder & CEO); board also lists Devika Sehgal and two nominee directors |
| Businesses | Primary-care aggregation network and OPD insurance / employee health-benefit products |
| Latest FY revenue | Approximately ₹89 crore in FY24 (Inc42 financials); FY25 reported in the ₹50–100 crore band (Tracxn) — aggregator estimates, not figures reviewed here |
| Latest FY profit/loss | Not cleanly disclosed; secondary trackers give conflicting figures (see The numbers) |
| Listed | Private — not listed on any exchange |
| Market value / last valuation | About $16.7 million reported as of April 2020 (Inc42 / PitchBook); no fresh valuation disclosed after the 2022 round |
| Key shareholders / CEO | CEO Varun Gera; backers include Blume Ventures, Rajiv Dadlani Group, Leo Capital, HR Fund, Allanasons |
What HealthAssure does
HealthAssure sells access to everyday healthcare, and it sells that access to whoever underwrites or sponsors it rather than to patients one by one. In practice that means three overlapping things:
- A primary-care network: roughly 3,200 primary-care medical centres across more than 1,000 cities, aggregated so a member can walk into a partnered clinic, diagnostic lab or pharmacy on cashless or discounted terms (company-stated, via YourStory and 2022 funding coverage).
- OPD insurance and health-benefit products: outpatient cover — consultations, diagnostics, dental, pharmacy — designed to sit alongside conventional hospitalisation policies, which historically excluded day-to-day care.
- Rails others rent: insurers (LIC, SBI Life are named partners) and large employers (GE, Deloitte, Deutsche Bank, Pearson are named clients) plug their members into the network instead of assembling one themselves (per 2022 funding coverage in India Infoline and People Matters).
The pitch, in one line: hospitalisation insurance is a solved distribution problem in India; outpatient care is not, and HealthAssure wants to be the plumbing for it.
The founding insight
Varun Gera did not arrive at healthcare by accident. He holds an MBA from the University of Notre Dame and had worked at E&Y, GE Money and ICICI Bank, where he was National Head of Premium Cards, before taking over as Chief Executive of UnitedHealthcare India from October 2006 to May 2011. Running an insurer taught him where the money did not flow: claims data clustered around hospitalisation, while the far more frequent outpatient interaction — the GP visit, the blood test, the prescription — sat outside almost every policy.
The founding insight was that this gap was structural, not accidental. Outpatient care is high-frequency and low-ticket, which makes it expensive to underwrite and easy to defraud, so insurers left it alone. Gera’s wager was that if someone built the network first — a dense, priced, quality-checked mesh of clinics, labs and pharmacies — then the insurance product could ride on top of it, and the same rails could be resold to employers running wellness budgets. HealthAssure began, in his telling, as a way to give consumers access to and discounts on primary care; the harder, more defensible business turned out to be the network beneath it.
The struggle years
HealthAssure spent most of its first decade as a slow-compounding infrastructure business, not a headline-grabbing one, and the record shows the strain of building a category that did not yet exist.
- A B2C idea that had to grow up. The company started aimed at consumers wanting cheaper primary care, but a discount-access model for individuals is hard to monetise. Over the decade it shifted its centre of gravity to corporates and insurers — the buyers with budgets and scale — turning a consumer app into a B2B2C distribution and network business.
- Slow capital for a slow category. The funding trail is telling: a first institutional cheque only around March 2018, roughly seven years after incorporation, followed by small top-ups. OPD insurance had no proven playbook, so investors funded it in modest increments rather than large bets.
- Buying capability rather than building it. In 2020 HealthAssure acquired the fitness startup FitMeIn, a sign it needed to bolt on wellness and engagement features it had not built organically, and to give the network more reasons for members to use it.
- Raising into a downturn. Its largest round closed in August 2022, into a funding winter; Gera framed it as raising “our largest round yet in such difficult market conditions,” an unusually candid acknowledgement that the environment was hostile.
The turning point
The clearest inflection is the ₹50 crore pre-Series B announced on 25 August 2022, led by the Rajiv Dadlani Group with Blume Ventures and Leo Capital. It matters less for the amount than for what sat on either side of it. Before the round, HealthAssure had raised only about ₹22 crore across its earlier rounds — a decade of building on a shoestring. This single round more than doubled the total capital ever put into the company, taking cumulative funding to roughly ₹72 crore (People Matters, Business Standard).
On the other side of the event, the company set an explicit ambition: reach ten times its then-current revenue within three years, aimed at an OPD-and-insurance opportunity it sized near $40 billion. The turning point, in other words, was the moment a patiently built network stopped being a science project and got the capital — and the stated growth mandate — to be scaled. Whether the 10x target lands is the open question the later numbers begin to answer.
The money behind it
HealthAssure is a lightly capitalised company by healthtech standards — cumulative funding is measured in tens of crore, not hundreds. The rounds, as recorded by Inc42, Crunchbase and Tracxn:
- Seed — March 2018: about $1.0 million, from the HR Fund (Inc42).
- Series A — July 2019: about $2.5 million, led by Blume Ventures (Inc42).
- Top-up — April 2020: about $0.78 million from Blume Ventures; a valuation of roughly $16.7 million was reported around this time (Inc42 / PitchBook).
- Top-up — May 2020: about $0.26 million from Allanasons Private Limited (Inc42).
- Pre-Series B — August 2022: ₹50 crore (reported at about $6.3 million at 2022 exchange rates), led by the Rajiv Dadlani Group with Blume Ventures and Leo Capital, plus family offices and HNIs (YourStory, Business Standard, Entrepreneur India).
What each backer changed:
- Blume Ventures is the throughline — it led the 2019 Series A, topped up in 2020, and returned in 2022, giving the company an early-stage anchor across its hardest years.
- Rajiv Dadlani Group led the 2022 round, bringing the largest single infusion and marquee-investor validation at a difficult moment.
- Leo Capital and the HR Fund widened the cap table toward growth and HR/benefits distribution.
Trackers put total funding at roughly $10.6–11.6 million (PitchBook, Tracxn), broadly consistent with the ~₹72 crore cumulative figure once earlier rounds are added in. No valuation has been disclosed since 2022; one 2022 write-up cited a far larger “₹220 crore raised” figure that no other source supports, so it is treated here as an outlier and excluded.
How it makes money
HealthAssure’s model is an aggregator-plus-underwriting stack. The money in and the money out, as the company and its coverage describe them:
- Money in — B2B contracts: corporates buy employee OPD and wellness programmes; insurers buy access to the network to make OPD products they can sell. Revenue is recurring and contract-based rather than transactional.
- Money in — the network as product: because HealthAssure has negotiated rates with ~3,200 centres, it can price outpatient care predictably and resell that predictability. The defensibility sits in the network density, not in any single app feature.
- Money out — network and delivery costs: payouts to clinics, labs and pharmacies, plus the technology and operations to run cashless authorisation across more than 1,000 cities.
- Where the margin sits: in the spread between what a corporate or insurer pays per member and what care actually costs across the network — an economics that only works at scale, because outpatient claims are frequent and small.
- The part people get wrong: HealthAssure is often filed under “insurance,” but it does not primarily carry insurance risk itself — it builds and operates the outpatient rails that let regulated insurers and employers offer OPD cover. It is closer to an HMO-style network and administrator than to a risk-carrying insurer.
The numbers
This is where caution is required. HealthAssure is private, its filings are not reproduced in full in accessible sources, and the secondary trackers disagree — sometimes with each other and sometimes internally. What can be said with attribution, unit ₹ crore:
| Financial year | Revenue (₹ crore) | Profit / loss (₹ crore) |
| FY24 | ~89 (Inc42 financials) | Not reliably disclosed |
| FY25 | Reported in the ₹50–100 crore band; trackers cite figures from ~₹62 crore to ~₹97 crore | Conflicting: one Inc42 view shows a positive PAT (~₹21 crore), another a small loss (~-₹5 crore) |
Reading the table honestly:
- Revenue scale: the company operates in the tens of crore of annual revenue. FY24 revenue is most consistently reported near ₹89 crore, about $9 million at $1 ≈ ₹96.0 (Inc42 financials).
- Direction is contested: Tofler flags a roughly 6.3% decline in total revenue for FY25, while other tracker snapshots imply growth — so the FY24-to-FY25 trend cannot be stated with confidence.
- Profitability is unclear: published PAT figures contradict each other by sign, not just magnitude, so no profit or loss number is asserted here. This is a data gap, not a finding.
- Company-stated growth (2022): revenue had “doubled year over year” and grown at roughly a 46% CAGR over five years — founder-stated at the time of the 2022 round, not independently audited here.
Where the money comes from
HealthAssure’s revenue is concentrated on the buy side, not the patient side — the surprise for a company branded around consumer healthcare is how little of its money comes directly from consumers.
- Corporates: large employers buying OPD and wellness for their workforces — named clients include GE, Deloitte, Deutsche Bank and Pearson (People Matters, India Infoline).
- Insurers: carriers that use the network to build and service OPD products — LIC and SBI Life are named partners (India Infoline).
- Geography: the network spans more than 1,000 cities, but the revenue-generating contracts sit with national corporates and insurers, which means demand is concentrated among a relatively small number of large accounts even as delivery is spread thin across the country.
- Scale of usage: more than 3 million customers serviced since 2011 (cumulative, company-stated) — a reach number, not an annual active number.
The dependency this creates is the theme of the risks below: a wide, expensive-to-run delivery footprint funded by a narrow, concentrated base of institutional buyers.
The risks
- Thin, frequency-heavy economics. Outpatient care is the hardest thing in health to insure profitably: claims are small, constant and easy to over-use. If per-member pricing is set even slightly below realised network cost, losses compound across millions of interactions. The margin lives in a narrow spread, and the aggregator absorbs the operational complexity.
- Buyer concentration. With revenue anchored in a handful of large corporates and insurers, the loss or renegotiation of a single major contract can swing a year — a structural vulnerability for a business whose costs (the 1,000-plus-city network) are largely fixed.
- Regulatory dependence. HealthAssure’s growth is coupled to how India’s insurance regulator (IRDAI) treats OPD cover and to insurers’ appetite for it. The company builds the rails but does not control whether regulated partners choose to run OPD products on them at scale.
- Uncertain, possibly volatile financials. The conflicting revenue direction (a reported FY25 decline in one source versus growth implied elsewhere) and the contradictory profit figures mean the business’s trajectory is genuinely unclear from the outside — itself a risk for a company still proving that OPD insurance can be a durable category rather than a perennial “next big market.”
The takeaway
The transferable lesson from HealthAssure is about sequencing. Gera did not start by selling insurance, the flashy layer; he spent a decade building the unglamorous network underneath it, because he had learned from inside an insurer that the product only works if the rails exist first. Building infrastructure ahead of the product that monetises it is slow, capital-starved and easy to mistake for failure — seven years to a first institutional round is a long time to look unremarkable. But it produces something a competitor cannot clone with a fundraise: a priced, dense, working network. The unresolved second half of the lesson is that owning the rails is necessary, not sufficient. Until the OPD-insurance category it helped invent proves it can carry real, profitable volume, HealthAssure remains a well-built answer to a question the market has not yet fully asked.
Frequently asked questions
What does HealthAssure actually do?
It aggregates roughly 3,200 primary-care centres, diagnostics and pharmacies across more than 1,000 Indian cities into one network, then sells access to that network to insurers and employers as OPD (outpatient) insurance and health-benefit products, rather than mainly selling to patients directly.
Who founded HealthAssure and when?
Varun Gera founded it in 2011 (the company, HealthAssure Private Limited, was incorporated on 14 October 2011). Before that he was Chief Executive of UnitedHealthcare India from 2006 to 2011, and had worked at ICICI Bank, GE Money and E&Y.
How much money has HealthAssure raised?
Roughly ₹72 crore cumulatively, or about $10.6–11.6 million by tracker estimates. Its largest round was a ₹50 crore pre-Series B in August 2022, led by the Rajiv Dadlani Group with Blume Ventures and Leo Capital.
Is HealthAssure profitable?
That cannot be confirmed from public sources. Secondary trackers give contradictory profit figures for its most recent year — one shows a positive profit, another a small loss — so no reliable profit or loss figure can be stated. Revenue is in the tens of crore.
How is HealthAssure different from a health insurer?
It does not primarily carry insurance risk. It builds and operates the outpatient-care network and administration that regulated insurers (such as LIC and SBI Life) and employers use to offer OPD cover — closer to an HMO-style network and administrator than to a risk-carrying insurer.
Sources
Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).
- Tofler — HealthAssure Private Limited company and financial summary (CIN U85100MH2011PTC223007), accessed September 2026.
- Inc42 — HealthAssure company, funding and financials profiles, accessed September 2026.
- Tracxn — HealthAssure Private Limited company profile, financials and investors, accessed September 2026.
- PitchBook — HealthAssure company profile: valuation, funding and investors, accessed September 2026.
- Crunchbase — HealthAssure organization and Varun Gera person profiles, accessed September 2026.
- YourStory — “HealthAssure raises Rs 50 Cr in Pre-Series B round from Rajiv Dadlani Group,” August 2022; and HealthAssure / Varun Gera profiles.
- Business Standard — “HealthAssure raises Rs 50 cr in pre-Series B funding led by Dadlani Group,” August 2022.
- Entrepreneur India — “HealthAssure Raises INR 500 Million In Pre-Series B Funding,” August 2022.
- India Infoline (indiainfoline.com) — “Rajiv Dadlani Group and Blume Ventures provide HealthAssure with Rs 50 crore,” August 2022.
- People Matters — “HealthAssure secures Rs 50 crore in Pre-Series B funding,” August 2022.
Found an error? Write to us and we’ll correct it in the open, dated, on the piece.